Anti-Activin Receptor Type IA antibody (ab66924)

Overview

  • Product nameAnti-Activin Receptor Type IA antibody
    See all Activin Receptor Type IA primary antibodies
  • Description
    Goat polyclonal to Activin Receptor Type IA
  • Tested applicationsSuitable for: WBmore details
  • Species reactivity
    Reacts with: Human
    Predicted to work with: Mouse, Rat, Cow, Dog
  • Immunogen

    Synthetic peptide:

    C-RKFKRRNQERLNPRD

    , corresponding to internal sequence amino acids 147-161 of Human Activin Receptor Type IA, according to NP_001096.1.

  • Positive control
    • Human Umbilical Cord lysate

Properties

Applications

Our Abpromise guarantee covers the use of ab66924 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

Application Abreviews Notes
WB
  • Application notesWB: Use at a concentration of 0.3 - 1.0 µg/ml. Detects a band of approximately 60 kDa (predicted molecular weight: 57 kDa).
    Peptide ELISA: antibody detection limit dilution 1/128,000.

    Not yet tested in other applications.
    Optimal dilutions/concentrations should be determined by the end user.
  • Target

    • FunctionOn ligand binding, forms a receptor complex consisting of two type II and two type I transmembrane serine/threonine kinases. Type II receptors phosphorylate and activate type I receptors which autophosphorylate, then bind and activate SMAD transcriptional regulators. Receptor for activin. May be involved for left-right pattern formation during embryogenesis.
    • Tissue specificityExpressed in normal parenchymal cells, endothelial cells, fibroblasts and tumor-derived epithelial cells.
    • Involvement in diseaseDefects in ACVR1 are a cause of fibrodysplasia ossificans progressiva (FOP) [MIM:135100]. FOP is a rare autosomal dominant disorder of skeletal malformations and progressive extraskeletal ossification. Heterotopic ossification in FOP begins in childhood and can be induced by trauma or may occur without warning. Bone formation is episodic and progressive, leading to extra-articular ankylosis of all major joints of the axial and appendicular skeleton, rendering movement impossible.
    • Sequence similaritiesBelongs to the protein kinase superfamily. TKL Ser/Thr protein kinase family. TGFB receptor subfamily.
      Contains 1 GS domain.
      Contains 1 protein kinase domain.
    • Cellular localizationMembrane.
    • Information by UniProt
    • Database links
    • Alternative names
      • Activin A receptor type I antibody
      • Activin A receptor type II like kinase 2 antibody
      • Activin receptor type I antibody
      • Activin receptor type-1 antibody
      • Activin receptor-like kinase 2 antibody
      • ACTR-I antibody
      • ACTRI antibody
      • Acvr1 antibody
      • ACVR1_HUMAN antibody
      • ACVR1A antibody
      • ACVRLK2 antibody
      • ALK 2 antibody
      • ALK-2 antibody
      • ALK2 antibody
      • FOP antibody
      • Hydroxyalkyl protein kinase antibody
      • Serine/threonine-protein kinase receptor R1 antibody
      • SKR1 antibody
      • TGF-B superfamily receptor type I antibody
      • TGFB superfamily receptor type I antibody
      • TSR-I antibody
      • TSRI antibody
      see all

    Anti-Activin Receptor Type IA antibody images

    References for Anti-Activin Receptor Type IA antibody (ab66924)

    ab66924 has not yet been referenced specifically in any publications.

    Product Wall

    Application Western blot
    Sample Rat Tissue lysate - whole (rat aorta)
    Loading amount 40 µg
    Specification rat aorta
    Gel Running Conditions Reduced Denaturing (9% SDS-PAGE)
    Blocking step BSA as blocking agent for 1 hour(s) and 0 minute(s) · Concentration: 5% · Temperature: 25°C
    Username

    Dr. Chrispina Hong

    Verified customer

    Submitted Jan 25 2013

    Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"